Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39316

DNAJC5 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

DNAJC5 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in the SK-HEP-1 hepatic adenocarcinoma line, providing a loss-of-function model for the DNAJC5 gene. DNAJC5 encodes cysteine string protein ?? (CSP??), a co-chaperone that activates HSC70 and regulates the SNARE complex components SNAP-25, Syntaxin-1A, and VAMP2, essential for exocytosis and protein quality control. This knockout enables studies of CSP??-dependent secretion, chaperone-mediated autophagy, and proteotoxic stress in liver adenocarcinoma. Key applications include analysis of SNARE protein expression, exosome release, and high-throughput drug screening for neurodegenerative disorders.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    DNAJC5

    Gene Identifier

    NCBI Gene ID 80331

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC5 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population in the SK-HEP-1 hepatic adenocarcinoma line, established through CRISPR/Cas9-mediated disruption of the DNAJC5 gene. This model provides a loss-of-function system for investigating the cellular roles of DNAJC5-encoded cysteine string protein ?? (CSP??) in the context of liver adenocarcinoma.

The SK-HEP-1 parental cell line was originally isolated from the ascitic fluid of a patient with liver adenocarcinoma and displays an epithelial morphology. SK-HEP-1 cells are negative for alpha-fetoprotein, differentiating them from hepatocellular carcinoma lines, and are widely employed as a model for hepatic adenocarcinoma to study tumor cell biology, including proliferation, migration, and drug sensitivity.

DNAJC5 encodes CSP??, a synaptic vesicle-associated co-chaperone that is critical for exocytosis and protein homeostasis. CSP?? stimulates the ATPase activity of HSC70 (HSPA8), facilitating the folding and assembly of SNARE complex components such as SNAP-25, Syntaxin-1A, and VAMP2. This chaperone cycle is essential for SNARE-mediated membrane fusion during neurotransmitter release and other secretory processes. Expression of DNAJC5 is regulated by upstream factors including heat shock factor 1 (HSF1) and is responsive to cellular stress stimuli and calcium influx. CSP?? also interacts with G protein subunits, linking it to diverse signaling pathways. Within the cellular network, DNAJC5 participates in chaperone-mediated autophagy and the unfolded protein response, highlighting its role in proteostasis.

In the hepatic adenocarcinoma context, knockout of DNAJC5 disrupts CSP??-dependent protein quality control and secretion, potentially altering the release of exosomes, cytokines, and matrix remodeling factors. Given the role of SNARE proteins in cancer cell secretion, loss of CSP?? may impair membrane trafficking and increase susceptibility to proteotoxic stress, offering insights into how cancer cells manage protein aggregation. This model connects the biology of neurodegeneration-associated proteins, such as CSP??, to liver cancer, where autophagy and stress responses are key determinants of tumor progression.

Researchers can utilize this polyclonal knockout product for Western blot analysis of SNARE proteins, co-immunoprecipitation of HSC70 complexes, and immunofluorescence localization of CSP??. Functional assays include exosome secretion measurements and cell viability tests under stress conditions. The model supports drug screening for compounds that modulate chaperone activity or SNARE complex function, particularly in the context of adult-onset neuronal ceroid lipofuscinosis (ANCL) and other neurodegenerative disorders. Additionally, it enables investigation of cross-talk between secretory pathways and autophagy in liver adenocarcinoma. For further technical information or custom cell engineering services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)